Search research articles
Contact Us
Filters
Showing results (91-100 of 98) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 98 results.
Brain Communications
|
October 15, 2021
Neurological complications induced by immune checkpoint inhibitors: a comprehensive descriptive case-series unravelling high risk of long-term sequelae
Léo Plaçais, Jean-Marie Michot, Stéphane Champiat, et al.
Cancer Medicine
|
May 31, 2021
Fortnightly or fractionated weekly docetaxel-cisplatin-5-FU as first-line treatment in advanced gastric and gastroesophageal junction adenocarcinoma: The randomized phase II DoGE study
Amélie Deleporte, Marc Van den Eynde, Frédéric Forget, et al.
Plos One
|
October 1, 2015
The Prognostic Significance of Metabolic Response Heterogeneity in Metastatic Colorectal Cancer
Alain Hendlisz, Amelie Deleporte, Thierry Delaunoit, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Efficacy and safety of short-course radiotherapy versus total neoadjuvant therapy in older rectal cancer patients: a randomised pragmatic trial (SHAPERS)
R Saúde-Conde, T Vandamme, M De Backer, et al.
Clinical Colorectal Cancer
|
August 18, 2021
Sex and Regorafenib Toxicity in Refractory Colorectal Cancer: Safety Analysis of the RegARd-C Trial
Caroline Vandeputte, Giacomo Bregni, Paraskevas Gkolfakis, et al.
Acta Oncologica (Stockholm, Sweden)
|
July 22, 2022
Circulating DNA in the neoadjuvant setting of early stage colon cancer
Giacomo Bregni, Andrea Pretta, Chiara Senti, et al.
JAMA Oncology
|
July 10, 2025
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Alessandro Audisio, Chiara Gallio, Vaneja Velenik, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 6, 2026
Mismatch repair deficiency or microsatellite instability in locally advanced rectal cancer patients treated with total neoadjuvant therapy
Nada Benhima, Alessandro Audisio, Chiara Gallio, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 98) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 98 results.
Brain Communications
|
October 15, 2021
Neurological complications induced by immune checkpoint inhibitors: a comprehensive descriptive case-series unravelling high risk of long-term sequelae
Léo Plaçais, Jean-Marie Michot, Stéphane Champiat, et al.
Cancer Medicine
|
May 31, 2021
Fortnightly or fractionated weekly docetaxel-cisplatin-5-FU as first-line treatment in advanced gastric and gastroesophageal junction adenocarcinoma: The randomized phase II DoGE study
Amélie Deleporte, Marc Van den Eynde, Frédéric Forget, et al.
Plos One
|
October 1, 2015
The Prognostic Significance of Metabolic Response Heterogeneity in Metastatic Colorectal Cancer
Alain Hendlisz, Amelie Deleporte, Thierry Delaunoit, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Efficacy and safety of short-course radiotherapy versus total neoadjuvant therapy in older rectal cancer patients: a randomised pragmatic trial (SHAPERS)
R Saúde-Conde, T Vandamme, M De Backer, et al.
Clinical Colorectal Cancer
|
August 18, 2021
Sex and Regorafenib Toxicity in Refractory Colorectal Cancer: Safety Analysis of the RegARd-C Trial
Caroline Vandeputte, Giacomo Bregni, Paraskevas Gkolfakis, et al.
Acta Oncologica (Stockholm, Sweden)
|
July 22, 2022
Circulating DNA in the neoadjuvant setting of early stage colon cancer
Giacomo Bregni, Andrea Pretta, Chiara Senti, et al.
JAMA Oncology
|
July 10, 2025
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Alessandro Audisio, Chiara Gallio, Vaneja Velenik, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 6, 2026
Mismatch repair deficiency or microsatellite instability in locally advanced rectal cancer patients treated with total neoadjuvant therapy
Nada Benhima, Alessandro Audisio, Chiara Gallio, et al.
Page
of 10